Does Combination Therapy with Statins and Fibrates Prevent Cardiovascular Disease in Diabetic Patients with Atherogenic Mixed Dyslipidemia?

Type 2 diabetes mellitus (T2DM) is associated with the development and progression of cardiovascular disease (CVD). Statins have an established efficacy in the management of dyslipidemia primarily by decreasing the levels of low-density lipoprotein cholesterol and thus decreasing CVD risk. They also...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Agouridis, Aris P., Rizos, Christos V., Elisaf, Moses S., Filippatos, Theodosios D.
Формат: Artigo
Язык:Inglês
Опубликовано: SBDR - Society for Biomedical Diabetes Research 2013
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063095/
https://ncbi.nlm.nih.gov/pubmed/24380091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2013.10.171
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы